Dermata Therapeutics, Inc. (DRMA) Social Stream
Dermata Therapeutics Inc (DRMA) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering Dermata Therapeutics Inc.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-17 | 2 | $14 | $9 | $11.5 | $1.28 | 798.44% |
| 2022-03-30 | 2 | $14 | $4 | $9 | $1.28 | 603.12% |
DRMA Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1 | 2 | 0 | 0 | 0 | 0 | 2 |
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- To contextualize these metrics, consider that out of all US stocks, Dermata Therapeutics Inc's upside potential (average analyst target price relative to current price) is higher than 195.46% of them.
- To contextualize these metrics, consider that out of all US stocks, Dermata Therapeutics Inc's number of analysts covering the stock is higher than 9.42% of them.
- In the context of all US stocks, Dermata Therapeutics Inc's average analyst price target is higher than 18.2% of them.
- In terms of how Dermata Therapeutics Inc fares relative to stocks in the nano market cap category, note that its variance in analysts' estimates is lower than -79.41% of that group.
Stocks similar to Dermata Therapeutics Inc in the Pharmaceutical Products industry regarding analyst recommendations and price targets are BNTC, VECT, and SMFL.
Is DRMA a Buy, Hold or Sell? See the POWR Ratings now!